The usual cause for the fund is to invest in rounds with 4 partakers. Despite the MMG Opportunities, startups are often financed by TEDCO, MedTech Innovator, Abell Foundation. The meaningful sponsors for the fund in investment in the same round are TEDCO, Emerald Development Managers, Abell Foundation.
Among the most successful fund investment fields, there are Medical Device, Biotechnology. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vixiar Medical.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2019.
Related Funds
Fund Name | Location |
Arches Capital | Chicago, Illinois, United States |
Fluke Venture Partners | Kirkland, United States, Washington |
Girls Ventures | California, Oakland, United States |
LF Capital | Beijing, Beijing, China |
N Capital Partners | - |
Navus Ventures | Netherlands, South Holland, The Netherlands |
Ralph Lauren Corporation | New York, New York, United States |
Robertson Stephens Partners | California, San Francisco, United States |
Shangde Heli Touzi | China, Zhejiang, Zhuji |
Shimadzu | Japan, Kyoto, Kyoto Prefecture |
Skytrace Capital | China, Shanghai |
Stout Street Capital | Colorado, Denver, United States |
Textron | Providence, Rhode Island, United States |
The Schmidt Family Foundation | California, Palo Alto, United States |
TVOAO.com | Beijing, Beijing, China |
V/G Ventures | - |
VCO Ventures | Germany, Hamburg |
VW Credit, Inc. | Herndon, United States, Virginia |
WSB Holding | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Vixiar Medical | $1M | 20 Mar 2019 | Baltimore, Maryland, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Vixiar Medical | $1M | 20 Mar 2019 | Baltimore, Maryland, United States |